source
- FDA staff raise concerns over data for Moderna’s mFlusiva flu vaccine ahead of advisory panelFDA staff have examined the evidence for Moderna's mFlusiva, an mRNA flu vaccine, and highlighted shortcomings in the data submitted to the agency. The Food and Drug Administration will convene an…
- Verge Labs launches AI tool to boost patient enrollment and trial efficiency; Moderna appoints new chief commercial officerVerge Labs announced a new artificial‑intelligence model designed to identify patients most likely to respond to a therapy, aiming to reduce dropout rates and increase the statistical power of clin…